Reuters: Hot Stocks: BRIEF-Catalyst Pharma drops in premarket after mid-stage results of study delayed

Reuters: Hot Stocks Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

BRIEF-Catalyst Pharma drops in premarket after mid-stage results of study delayed Sep 26th 2012, 12:54 NEW YORK, Sept 26 | Wed Sep 26, 2012 8:54am EDT NEW YORK, Sept 26 (Reuters) - Catalyst Pharmaceutical Partners Inc : * Catalyst Pharma drops 18.5 percent to $1.50 in premarket after mid-stage results of cocaine addicition study delayed

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions